期刊
ADVANCED BIOLOGY
卷 5, 期 8, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/adbi.202100535
关键词
automation; intelligent microfluidics; microfluidics; organoid engineering; organoids; organoids-on-a-chip; translational medicine
资金
- National Natural Science Foundation of China [61971255, 62088102]
- Natural Science Foundation of Guangdong Province [2021B1515020092]
- Shenzhen Science and Technology Innovation Commission [RCYX20200714114736146, KCXFZ202002011010508]
- Shenzhen Bay Laboratory Fund [SZBL2020090501014]
Organoid technology has advanced rapidly, but its practical applications are still limited. Integrating engineering and artificial intelligence into research practices may accelerate the translation of organoids, with organoids-on-a-chip proposed as an ideal platform for achieving high-throughput, automated manipulation, and intelligent monitoring and control. Once established and adopted by the scientific community, rapid translation of organoids from laboratories to clinics and pharmaceutical industry may be realized.
Organoid technology has developed at an impressive speed during the past decade. Still, organoids are not widely used in practical applications as expected. It is believed that this translation can be greatly accelerated with the integration of engineering and artificial intelligence into current research practices. It is proposed that this approach is the missing link to realize key milestones in organoid technology, namely, high-throughput, homogeneous, and standardized production, automated manipulation, and intelligent monitoring, evaluation, and control via integrated on-chip instrumentation and artificial intelligence. It is suggested that organoids-on-a-chip are the ideal platform to achieve these feats. Once these techniques are established and adopted by the scientific community, the rapid translation of organoids may be seen from laboratories to the clinics and pharmaceutical industry.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据